For 25 years Carousel Capital has managed more than $2B in private equity commitments across six funds and co-investment vehicles used to invest in businesses that have an aggregate enterprise value exceeding
$8 billion
Carousel Capital has not made a CEO change in any platform investment made since 2004other than planned retirements
79%of our investments are first-time institutional equity capital
Carousel Capital investments have been in companies that have had 164%Average revenue growth during our partnership
Carousel Capital investments have been in companies that have had 205%average EBITDA growth during our partnership
We look for the right business, the right situation, and the right people. Both our returns and our CEO relationships show the results.
Our Success
Trusted Partnerships
Transflo is the leading provider of tech-enabled revenue cycle, document management and invoicing solutions to the transportation industry.
APEX Analytix is a leading provider of audit, recovery and compliance technology and services to global Fortune 1000 companies.
Joe Hudson’s Collision Center is a leading provider of automotive collision repair services in the Southeastern United States.
A leading provider of outsourced database management, marketing program administration, data collection and data analysis services to the agriculture/crop protection, animal health and healthcare industries.
Axium Healthcare Pharmacy, Inc. is a leading independent specialty pharmacy that provides comprehensive disease-management programs to meet the needs of patients with rare or chronic conditions.
![Carousel Capital Announces Majority Exit of [apexanalytix] to KKR](https://manage.carouselcapital.com/public/content/news/Apex-Analytics-web_feat.jpg)
Carousel Capital is pleased to announce that KKR, a leading global investment firm, has signed a definitive agreement to acquire a majority interest in apexanalytix®. Carousel Capital will remain a significant minority owner in the Company alongside KKR.